Exploring the Frontiers of Biotech and Longevity: A Conversation with Infinita City's Niklas Anzinger
In this episode, Jason Wright interviews Niklas Anzinger, the founder of Infinita City, a pioneering biotech hub focused on accelerating breakthroughs in human health and longevity through innovative governance and community building. Niklas discusses the shortcomings of the FDA, the importance of creating novel biotech jurisdictions, and the potential for AI and digital currencies to revolutionize healthcare. The conversation also delves into the exciting vision for Infinita City and its role in transforming the future of biotech innovation.
00:00 Welcome and Introduction
00:50 Meet Nicholas: Founder of Infinite City
03:07 Nicholas' Journey and Vision
05:57 Challenges in Healthcare and Regulation
12:29 The Concept of Biohacking and Longevity
17:47 Infinite City: A Biotech Haven
21:30 The Future of Biotech and Global Hubs
26:24 Business Model and Digital Currency
31:10 Understanding Stablecoins
32:52 Residency and Membership Options
34:27 Supporting Biotech Innovators
35:55 Challenges in Drug Development
40:22 AI in Biotech Research
42:44 The Future of Longevity
47:45 Empowering Personal Health Data
51:41 Innovations in Health Insurance
54:35 Final Thoughts and Takeaways
